Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Rothberg

Showing results (21-30 of 417) with videos related to

Pageof 42
Sort By:
JAMA Internal Medicine|July 11, 2018
Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit VaccinePhuc Le, Michael B Rothberg
Journal of General Internal Medicine|January 20, 2026
Coverage is the Key to Realizing the Promise of SemaglutideHamlet Gasoyan, Michael B Rothberg
Journal of General Internal Medicine|November 1, 2025
Response to Fan and LiuMichael B Rothberg, Tarini Gunaratne
Journal of General Internal Medicine|October 16, 2016
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness AnalysisPhuc Le, Michael B Rothberg
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2022
Reply to authorPriscilla Kim, Michael B Rothberg
Annals of Internal Medicine|September 8, 2015
Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 YearsPhuc Le, Michael B Rothberg
JAMA|April 14, 2011
Herpes zoster vaccine and older adultsMichael B Rothberg, Kenneth J Smith
JAMA Internal Medicine|April 2, 2019
Balance Between Best Practice and Patient Satisfaction: Antimicrobial Stewardship in Telemedicine-ReplyKathryn A Martinez, Michael B Rothberg
JAMA Network Open|March 15, 2021
Soliciting Patients to Help Define Treatment ThresholdsKathryn A Martinez, Michael B Rothberg
Journal of General Internal Medicine|March 10, 2026
Breaking the Genetic Counseling Bottleneck in BRCA TestingKathryn A Martinez, Michael B Rothberg
Pageof 42

Showing results (21-30 of 417) with videos related to

Sort By:
Pageof 42
JAMA Internal Medicine|July 11, 2018
Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit VaccinePhuc Le, Michael B Rothberg
Journal of General Internal Medicine|January 20, 2026
Coverage is the Key to Realizing the Promise of SemaglutideHamlet Gasoyan, Michael B Rothberg
Journal of General Internal Medicine|November 1, 2025
Response to Fan and LiuMichael B Rothberg, Tarini Gunaratne
Journal of General Internal Medicine|October 16, 2016
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness AnalysisPhuc Le, Michael B Rothberg
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2022
Reply to authorPriscilla Kim, Michael B Rothberg
Annals of Internal Medicine|September 8, 2015
Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 YearsPhuc Le, Michael B Rothberg
JAMA|April 14, 2011
Herpes zoster vaccine and older adultsMichael B Rothberg, Kenneth J Smith
JAMA Internal Medicine|April 2, 2019
Balance Between Best Practice and Patient Satisfaction: Antimicrobial Stewardship in Telemedicine-ReplyKathryn A Martinez, Michael B Rothberg
JAMA Network Open|March 15, 2021
Soliciting Patients to Help Define Treatment ThresholdsKathryn A Martinez, Michael B Rothberg
Journal of General Internal Medicine|March 10, 2026
Breaking the Genetic Counseling Bottleneck in BRCA TestingKathryn A Martinez, Michael B Rothberg
Pageof 42